Greenlanders have told the Daily Record they will follow the example of Braveheart hero William Wallace to defend their “freedom” in the face of threats from Donald Trump. As the US President vows to ...

The mistake is among a myriad of historical blunders that are shown in the iconic flick THE cult classic Braveheart has been watched and loved endlessly since the 90s – and yet it’s only now that even ...

It’s time to pay tribute to an absolute all time classic! The sort of film that just never gets old, regardless of how many times you've watched it, as we’re going to look at the 1995 historical epic ...

Bristol Myers Squibb currently has the only drug approved specifically for treating obstructive hypertrophic cardiomyopathy, a debilitating disorder that can progress to heart failure. But safety ...

With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust with big names in an emerging heart disease drug arena. Backed by ...

Board to include Chris Viehbacher as Chair, with investor syndicate led by Andreessen Horowitz, Forbion, and OrbiMed with participation from Enavate Sciences (a platform of Patient Square Capital) and ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It’s one of the largest ...

NEW YORK CITY – Curtis Sliwa says he’s charging into the final stretch of New York City’s mayoral race like "Braveheart" — confident, defiant and ready to die on his sword for the city he loves. In an ...

Braveheart Bio has waded into the fight for a heart disease market, paying (PDF) $65 million upfront for a rival to Bristol Myers Squibb’s Camzyos and Cytokinetics’ aficamten. Jiangsu Hengrui ...

Where: 874 NY-43, Stephentown, N.Y. My experience: After I spent a few hours at Hancock Shaker Village, I still had some energy left and didn’t want to go back home just yet. I love a good bookstore, ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...